CHPA appointment
This article was originally published in The Tan Sheet
Executive Summary
Heinz Schneider, MD, will assume his new role as VP-Regulatory & Scientific Affairs July 1, the Consumer Healthcare Products Association announces May 5. Schneider most recently served as head of international regulatory affairs at Boots Healthcare International from 2004-2006, and was named global director of regulatory, safety and environment after BHI was acquired by Reckitt Benckiser in October. He takes the place of Doug Bierer, who left CHPA in July (1"The Tan Sheet" July 25, 2005, In Brief)...
You may also be interested in...
People In Brief
CHPA scientists Schneider, Roehrig exit
CHPA’s Bierer
Douglas Bierer, PhD, is resigning from his post as VP - Regulatory & Scientific Affairs for personal reasons, the Consumer Healthcare Products Association announces July 22. "I've enjoyed my time with CHPA and have high hopes for where the Association is going," Bierer said, though he admits "the weekly commute between CHPA's offices in D.C. and my family in Ohio has been difficult." Bierer has worked in the OTC industry for nearly 30 years and plans to remain involved with the association following his departure July 28. Lorna Totman, PhD, senior director, scientific affairs & toxicology, will serve as acting VP of the department until Bierer's permanent replacement is hired...
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.